In fact, although cytoprotective properties on renal tissue derived from the amelioration of insulin cannot be excluded, the results obtained in type 1 diabetes models [56, 57] suggest extra-pancreatic (renoprotective) effects of GLP-1/GLP-1R. Here, GLP1R is linked to type 1 diabetes mellitus.